A 28-year-old man with a 10-year history of type 1 diabetes mellitus presents with nephrotic syndrome. Kidney biopsy shows nodular glomerulosclerosis with capillary loop obliteration and basement membrane thickening. Which of the following is NOT characteristic of diabetic nephropathy?

Explanation

## Diabetic Nephropathy — Pathologic Features **Key Point:** Diabetic nephropathy is a **non-immune** glomerular disease characterized by basement membrane thickening, nodular glomerulosclerosis (Kimmelstiel-Wilson lesions), and hyaline arteriolosclerosis. Immunofluorescence is typically **negative or shows only non-specific IgG and albumin** — NOT IgA or C3 deposits. ### Pathologic Hallmarks of Diabetic Nephropathy | Feature | Characteristic | |---------|----------------| | **Glomerular changes** | Diffuse and nodular glomerulosclerosis | | **Nodular lesions** | Kimmelstiel-Wilson nodules (PAS+, diastase-resistant) | | **Capillary walls** | Thickened basement membrane (>200 nm) | | **Arteriolar changes** | Hyaline arteriolosclerosis (afferent & efferent) | | **Immunofluorescence** | Negative or non-specific IgG/albumin only | | **Electron microscopy** | Thickened GBM, effacement of foot processes | **High-Yield:** The **absence of immune deposits** on immunofluorescence is a key diagnostic feature that distinguishes diabetic nephropathy from immune-mediated GN (IgA nephropathy, lupus, membranous nephropathy). ### Why IgA and C3 Deposits Are NOT Seen in Diabetic Nephropathy **Key Point:** Diabetic nephropathy is a **metabolic/hemodynamic disease**, not an immune-mediated glomerulonephritis. The pathogenesis involves: 1. Hyperglycemia → advanced glycation end products (AGEs) 2. Increased intraglomerular pressure (glomerular hyperfiltration) 3. TGF-β activation → fibrosis and sclerosis 4. Oxidative stress and inflammation These mechanisms do **not** activate the complement cascade or lead to immune complex deposition. **Warning:** If a diabetic patient presents with IgA or C3 deposits on IF, consider **concurrent IgA nephropathy** or another immune GN — this is a separate diagnosis requiring different management. ### Clinical & Pathologic Progression ```mermaid flowchart TD A[Type 1 or 2 DM]:::outcome --> B[Glomerular hyperfiltration<br/>GFR > 120 mL/min]:::outcome B --> C[Basement membrane thickening<br/>Mesangial expansion]:::outcome C --> D[Diffuse glomerulosclerosis<br/>Nodular Kimmelstiel-Wilson lesions]:::outcome D --> E[Progressive proteinuria<br/>Nephrotic range]:::outcome E --> F[Declining GFR<br/>CKD Stage 3–5]:::outcome F --> G[ESRD<br/>Dialysis/Transplant]:::urgent H[Hypertension<br/>Poor glycemic control]:::decision -.accelerates.-> D I[ACE inhibitor/ARB<br/>Tight BP control<br/>SGLT2i]:::action -.slows progression.-> F ``` ### Other Pathologic Features **Hyaline Arteriolosclerosis:** - Homogeneous, eosinophilic material in vessel walls - Affects both afferent and efferent arterioles (pathognomonic for diabetes) - Results from AGE deposition and hypertension **Kimmelstiel-Wilson Nodules:** - Nodular glomerulosclerosis with capillary loop obliteration - PAS-positive, diastase-resistant (composed of basement membrane material and collagen) - Seen in ~25% of type 1 DM and ~10% of type 2 DM with nephropathy **GFR Decline Despite Optimal Control:** - Some patients progress to ESRD despite excellent glycemic and blood pressure control - Reflects underlying genetic susceptibility and irreversible glomerular damage - Highlights the importance of early intervention with ACE-I/ARB and SGLT2 inhibitors **Clinical Pearl:** The presence of **non-nephrotic proteinuria with preserved GFR** in a diabetic patient, followed by **progressive proteinuria and declining GFR**, is the classic presentation of diabetic nephropathy. Sudden onset of nephrotic syndrome or hematuria should raise suspicion for concurrent immune GN.